FDA approves Abbott’s slimmed-down spinal cord stimulator that can get by on 5 recharges a year
Just a few months after upgrading its portfolio of recharge-free spinal cord stimulators with FDA approval for a new version of the technology, Abbott has done the same for its line of rechargeable neurostimulation devices.